4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-010004
CHIEF FINANCIAL OFFICER gave up 1,617 shares (to pay taxes)
- CHIEF FINANCIAL OFFICER acquired 3,342 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-04-01 | Option exercise | +1,750 | 25,132 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-04-01 | Option exercise | +1,592 | 26,724 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-04-01 | Shares withheld for taxes | −847 | $21.77 | $18,439 | 25,877 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-04-01 | Shares withheld for taxes | −770 | $21.77 | $16,763 | 25,107 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-04-01 | Grant or award · Share Option | +29,480 | 29,480 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-04-01 | Grant or award · Restricted Share Unit | +7,382 | 7,382 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-04-01 | Grant or award · Performance Share Unit | +14,765 | 14,765 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-04-01 | Option exercise · Restricted Share Unit | −1,750 | 3,500 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-04-01 | Option exercise · Restricted Share Unit | −1,592 | 4,773 | D | ||
Loading xslF345X05/form4-04032025_090414.xml…